Browse by:
MetroWest/495

Guilty plea in New England Compounding Center case

Grant Welker |

A pharmacy technician involved in the deadly fungal meningitis case traced to Framingham's New England Compounding Center has pleaded guilty to nine counts of mail fraud.

Ameresco completes DEA solar facility

Framingham renewable and efficiency energy firm Ameresco has completed a 2.5-megawatt solar energy system near the U.S.-Mexico border to help power a U.S. Drug Enforcement Agency facility.

Marlborough plaza sells for $6.3M

A commercial plaza on Route 20 in Marlborough has sold for $6.3 million to a Texas investment company.

Rocco's Doughnut Co. adding Westborough location

Grant Welker |

Rocco's Doughnut Co., a Millbury doughnut shop, is expanding to a second location in Westborough later this year directly behind a Dunkin' Donuts.

Hologic subsidiary lands laughing gas rights

A subsidiary of Marlborough medical device firm Hologic has landed the U.S. and Canadian distribution rights of a Pennsylvania medical equipment manufacturer’s nitrous oxide and oxygen systems.

Biostage eyes FDA application in 2019

Despite just $5.8 million in cash to its name, Holliston organ bioengineering firm Biostage is eyeing a 2019 U.S. Food and Drug Administration application for its esophagus-regenerating device.

Inc. 5000 honors 16 fast-growing Central Mass. firms

Zachary Comeau |

A total of 16 Central Massachusetts companies made Inc. 5000's 2018 list of the 5,000 fastest growing companies in the country.

Nashoba Valley Medical Center president resigning

Grant Welker |

The president of Nashoba Valley Medical Center, Sal Perla, has resigned, the Ayer hospital announced Tuesday.

RXi Pharmaceutics extends runway in Q2

Zachary Comeau |

Despite reporting just $58,000 in second-quarter revenues, Marlborough drugmaker RXi Pharmaceuticals was able to significantly reduce its net loss, reduce its cash burn and extend its runway.

ReWalk shares dive 19% after lackluster earnings report

Shares medical device maker ReWalk Robotics dropped 19 percent at Tuesday's open after the company reported a loss of $5.8 million with $9.1 million in cash left on its balance sheet.

ADVERTISEMENTS
Copyright 2017 New England Business Media